TrialCancer medicine2013

Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab.

Yingmiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.